AJP - Regulatory, Integrative and Comparative Physiology, Vol 264, Issue 2 244-R249, Copyright © 1993 by American Physiological Society

ARTICLES

CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats

S. C. Weatherford, W. B. Laughton, J. Salabarria, W. Danho, J. W. Tilley, L. A. Netterville, G. J. Schwartz and T. H. Moran
Department of Neurobiology, Hoffmann-LaRoche, Nutley, New Jersey 07110.

Cholecystokinin-JMV-180 (JMV-180) is an analogue of cholecystokinin C-terminal octapeptide (CCK-8), which has been shown to be an agonist at the proposed CCK pancreatic high-affinity site and a functional antagonist at the pancreatic low-affinity site in rats and to have agonist activity at both high- and low-affinity sites in the mouse. In this study we used JMV-180 to evaluate the potential participation of these two CCK-A sites in the satiety effect of CCK-8 in rats and mice. When tested at doses that ranged from 0.01 to 9.2 mumol/kg, JMV-180 did not reliably affect food intake of solid or liquid test diets in rats. When combined with CCK-8 (3.2 or 8.5 nmol/kg) JMV-180 dose dependently reversed the satiety effect of CCK-8. In contrast to these results in the rat, both JMV-180 (3.7-14.8 mumol/kg) and CCK-8 (1.7-6.8 nmol/kg) dose dependently reduced the intake of 20% sucrose in mice. Both CCK-8- and JMV-180-induced suppression of food intake were attenuated by the CCK-A antagonist MK-329 (24.8 nmol/kg). The results of these studies suggest that agonist activity at sites pharmacologically similar to the CCK pancreatic high-affinity site is not sufficient for expression of CCK satiety, whereas agonist activity at low-affinity-like sites is necessary to reduce food intake. Thus the anorexic activity of CCK appears to be mediated through an interaction with a receptor site pharmacologically similar to the pancreatic low-affinity CCK receptor site.

This article has been cited by other articles:

				T. H. Moran and K. P. Kinzig Gastrointestinal satiety signals II. Cholecystokinin Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G183 - G188. [Abstract] [Full Text] [PDF]

				S. M. Simasko and R. C. Ritter Cholecystokinin activates both A- and C-type vagal afferent neurons Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1204 - G1213. [Abstract] [Full Text] [PDF]

				S. M. Simasko, J. Wiens, A. Karpiel, M. Covasa, and R. C. Ritter Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1303 - R1313. [Abstract] [Full Text] [PDF]

				T. O. Lankisch, Y. Tsunoda, Y. Lu, and C. Owyang Characterization of CCKA receptor affinity states and Ca2+ signal transduction in vagal nodose ganglia Am J Physiol Gastrointest Liver Physiol, June 1, 2002; 282(6): G1002 - G1008. [Abstract] [Full Text] [PDF]

				Y. Li, J. Zhu, and C. Owyang Electrical physiological evidence for highand low-affinity vagal CCK-A receptors Am J Physiol Gastrointest Liver Physiol, August 1, 1999; 277(2): G469 - G477. [Abstract] [Full Text] [PDF]

				L. Isenman, C. Liebow, and S. Rothman The endocrine secretion of mammalian digestive enzymes by exocrine glands Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E223 - E232. [Abstract] [Full Text] [PDF]